ERC-AG-LS4
ERC-AG-LS4
Programme: H2020
66 projects · €161,684,626 total EU contribution (project-level) · 53 participating organizations · 14 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€161,684,626
Countries active
Participant organizations by country (headquarters in CORDIS).
- UK (12)
- Germany (8)
- France (5)
- Italy (5)
- CH (4)
- Spain (4)
- SE (3)
- AT (2)
- FI (2)
- IL (2)
- Netherlands (2)
- DK (1)
- EL (1)
- LB (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- KI5 projects · SE
- EPFL4 projects · CH
- IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE4 projects · UK
- HELSINGIN YLIOPISTO3 projects · FI
- INSERM3 projects · FR
- THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE3 projects · UK
- ETH Zürich2 projects · CH
- IRB BARCELONA - CERCA2 projects · ES
- FUNDACION SECTOR PUBLICO ESTATAL CENTRO NACIONAL INVESTIGACIONES ONCOLOGICAS CARLOS III2 projects · ES
- .2 projects · IT
- IMBA2 projects · AT
- ISTITUTO EUROPEO DI ONCOLOGIA SRL2 projects · IT
Projects
Page 3 of 7
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Discovery of Type 2 Diabetes Targets ICEBERG · 233285 | FP7 | €2,500,000 | €2,500,000 | Details |
Switchable in vivo genetic models to identify cancer drug targets Oncoswitch · 294851 | FP7 | €2,483,236 | €2,483,236 | Details |
Intersecting hallmarks of cancer: mechanisms of and interplay between invasion and angiogenesis, guiding new strategies for cancer therapy HALLMARKS-TO-THERAPY · 322491 | FP7 | €2,500,000 | €2,500,000 | Details |
An Integrated Network of Glucose Sensing Cells in Glucose Homeostasis INSIGHT · 268946 | FP7 | €2,499,421 | €2,499,421 | Details |
A genome editing-based approach to study the stem cell hierarchy of human colorectal cancers EDITCRC · 340176 | FP7 | €2,499,405 | €2,499,405 | Details |
An in vivo imaging approach to understand pancreatic beta-cell signal-transduction BETAIMAGE · 338936 | FP7 | €2,499,590 | €2,499,590 | Details |
DNA methylation, hydroxymethylation and cancer"" DNAMET · 294666 | FP7 | €2,298,000 | €2,298,000 | Details |
Locomotion, hunting and habitat utilisation among large African carnivores and their prey LOCATE · 323041 | FP7 | €3,079,643 | €3,079,643 | Details |
Connecting the activities of c-Myc in genome regulation, cellular growth control and oncogenesis MYCNEXT · 268671 | FP7 | €2,494,000 | €2,494,000 | Details |
The Role of Lipolysis in the Pathogenesis of Cancer-associated Cachexia LipoCheX · 340896 | FP7 | €2,499,446 | €2,499,446 | Details |